• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Search 
    •   QMRO Home
    • Search
    •   QMRO Home
    • Search
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Discover

    AuthorMathur, R (18)Baumbach, A (12)Petersen, SE (11)Priebe, S (11)Smeeth, L (11)Mathur, A (10)Wragg, A (8)Khaw, K-T (7)Luben, R (7)Manchanda, R (7)... View MoreSubjectHumans (336)
    Middle Aged (336)
    Female (301)Male (288)Aged (224)Adult (222)Young Adult (91)Aged, 80 and over (75)Adolescent (67)United Kingdom (56)... View MoreDate Issued2020 - 2023 (50)2010 - 2019 (272)2000 - 2009 (6)1990 - 1999 (8)
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 51-60 of 336

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Effect of Mammography Screening on Mortality by Histological Grade. 

    Tabar, L; Chen, TH-H; Yen, AM-F; Chen, SL-S; Fann, JC-Y; Chiu, SY-H; Ku, MMS; Wu, WY-Y; Hsu, C-Y; Chen, Y-Y;... (American Association for Cancer Research, 2017-11-17)
    Background: It has been asserted that mammography screening preferentially benefits those with less aggressive cancers, with lesser or no impact on more rapidly progressing and therefore more life-threatening tumors.Methods: ...
    Thumbnail

    Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. 

    Manchanda, R; Legood, R; Pearce, L; Menon, U (2015-12)
    OBJECTIVE: To define risk thresholds for cost-effectiveness of risk-reducing salpingo-oophorectomy (RRSO) for ovarian cancer (OC) prevention in low/intermediate risk postmenopausal women. METHODS: A decision-analytic model ...
    Thumbnail

    Monetary cost for time spent in everyday physical activities. 

    Hsu, AS; Vlaev, I (2014-05)
    We measured utility curves for the hypothetical monetary costs as a function of time engaged in three everyday physical activities: walking, standing, and sitting. We found that activities requiring more physical exertion ...
    Thumbnail

    Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial. 

    MacDonald, TM; Williams, B; Webb, DJ; Morant, S; Caulfield, M; Cruickshank, JK; Ford, I; Sever, P; Mackenzie, IS; Padmanabhan, S;... (2017-11-18)
    BACKGROUND: Guidelines for hypertension vary in their preference for initial combination therapy or initial monotherapy, stratified by patient profile; therefore, we compared the efficacy and tolerability of these approaches. ...
    Thumbnail

    Intralesional steroid for orbital manifestations of Rosai-Dorfman disease. 

    Petrushkin, H; Salisbury, J; O'Sullivan, E (2015-07)
    Thumbnail

    Carbonaceous particulate matter on the lung surface from adults living in São Paulo, Brazil. 

    Padovan, MG; Whitehouse, A; Gouveia, N; Habermann, M; Grigg, J (2017)
    OBJECTIVES: We therefore sought to identify the exposures associated with lung surface in long-term residents of São Paulo, Brazil. METHODS: Lung surface carbon were analyzed in 72 autopsy specimens by image analysis. ...
    Thumbnail

    Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma. 

    Israel, E; Roche, N; Martin, RJ; Colice, G; Dorinsky, PM; Postma, DS; Guilbert, TW; van Aalderen, WMC; Grigg, J; Hillyer, EV;... (2015-06)
    RATIONALE: Guidelines advocate adding long-acting β-agonist (LABA) to inhaled corticosteroid as the preferred step-up therapy to increasing inhaled corticosteroid dose for patients with uncontrolled asthma on inhaled ...
    Thumbnail

    Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial. 

    Mallewa, J; Szubert, AJ; Mugyenyi, P; Chidziva, E; Thomason, MJ; Chepkorir, P; Abongomera, G; Baleeta, K; Etyang, A; Warambwa, C;... (Elsevier/Science Direct, 2018-04-10)
    BACKGROUND: In sub-Saharan Africa, severely immunocompromised HIV-infected individuals have a high risk of mortality during the first few months after starting antiretroviral therapy (ART). We hypothesise that universally ...
    Thumbnail

    Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial. 

    Foster, GR; Agarwal, K; Cramp, ME; Moreea, S; Barclay, S; Collier, J; Brown, AS; Ryder, SD; Ustianowski, A; Forton, DM;... (2018-06)
    Many direct-acting antiviral regimens have reduced activity in people with hepatitis C virus (HCV) genotype (GT) 3 infection and cirrhosis. The C-ISLE study assessed the efficacy and safety of elbasvir/grazoprevir (EBR/GZR) ...
    Thumbnail

    Interpreting population reach of a large, successful physical activity trial delivered through primary care. 

    Kerry, SM; Morgan, KE; Limb, E; Cook, DG; Furness, C; Carey, I; DeWilde, S; Victor, CR; Iliffe, S; Whincup, P;... (BioMed Central Ltd, 2018-01-23)
    BACKGROUND: Failure to include socio-economically deprived or ethnic minority groups in physical activity (PA) trials may limit representativeness and could lead to implementation of interventions that then increase health ...
    • 1
    • . . .
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • . . .
    • 34
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.